Phillip Hay

7.5k citations

116 papers · 4.3k indexed · 1 hit paper · h-index 34

Impact in

Microbiology top 0.1%
- Reproductive tract infections research
Virology top 1%
- HIV Research and Treatment

Papers in

Microbiology 77
- Reproductive tract infections research 77
Virology 16
- HIV Research and Treatment 16

Co-authors: D Taylor‐Robinson Pippa Oakeshott Austin Ugwumadu Fiona Reid Isaac Manyonda Janez Tomažič Sorin Rugină Elizabeth J. Phillips
Journals: Sexually Transmitted Infections (18 papers)International Journal of STD & AIDS (9 papers)BJOG An International Journal of Obstetrics & Gynaecology (5 papers)Clinical Infectious Diseases (4 papers)Current Opinion in Infectious Diseases (4 papers)
Partner nations: United Kingdom United States Spain

In The Last Decade

Phillip Hay

114 papers receiving 4.1k citations

Hit Papers

align trajectories log scale

HLA-B*5701 Screening for Hypersensitivity to Abacavir 2008 · 1.2k citations

Peers

Countries citing papers authored by Phillip Hay

Since Specialization

Citations

This map shows the geographic impact of Phillip Hay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Hay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Hay more than expected).

Fields of papers citing papers by Phillip Hay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Hay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Hay. The network helps show where Phillip Hay may publish in the future.

Co-authors

The 25 scholars most cited alongside Phillip Hay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Phillip Hay Line = papers co-authored together Phillip Hay links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Laboratory adverse events and discontinuation of therapy according to CD4+ cell count at the start of antiretroviral therapy AIDS ·Sophie José, Killian Quinn, Teresa Hill, Clifford Leen, John Walsh, Phillip Hay, Martin Fisher, Frank A. Post, Mark Nelson, Mark Gompels, Margaret Johnson, David Chadwick, Richard Gilson, Caroline Sabin, Sarah Fidler	2014	8
2	How likely is environmental or patient cross-contamination ofChlamydia trachomatisDNA to lead to false positive results in patients attending our clinic? Sexually Transmitted Infections ·Jamal N. Abdul-Rahman, Sophie José, Aguinaldo Jacinto Queco, Mark Pakianathan, Caroline Sabin, S Tariq Sadiq, Phillip Hay, Tim Planche	2012	6
3	Where do sexually active female London students go to access healthcare? Evidence from the POPI (Prevention of Pelvic Infection) chlamydia screening trial Sexually Transmitted Infections ·Muhammad Faizan Akram Muhammad Umair, Sarah R Kerry, Fiona Reid, Phillip Hay, Sally Kerry, Adamma Aghaizu, Pippa Oakeshott	2012	7
4	Timing of progression from Chlamydia trachomatisinfection to pelvic inflammatory disease: a mathematical modelling study BMC Infectious Diseases ·Sereina A. Herzog, Christian L. Althaus, Janneke C. M. Heijne, Pippa Oakeshott, Sally Kerry, Phillip Hay, Nicola Low	2012	41
5	Current perspectives on the management and prevention of antiretroviral-associated lipoatrophy Journal of Antimicrobial Chemotherapy ·David R. Phillips, Phillip Hay	2008	7
6	Thalidomide Treatment for Refractory HIV‐Associated Colitis: A Case Series Clinical Infectious Diseases ·J. Ma, Joseph N Jarvis, E.G.L. Wilkins, Phillip Hay	2008	9
7	Recurrent bacterial vaginosis Current Opinion in Infectious Diseases ·Phillip Hay	2008	42
8	Community-based trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial Trials ·Pippa Oakeshott, Sally Kerry, Helen Atherton, Adamma Aghaizu, Sima Hay, D Taylor‐Robinson, Ian Simms, Phillip Hay	2008	18
9	Performance of the automated Abbott RealTime™ HIV-1 assay on a genetically diverse panel of specimens from London: Comparison to VERSANT HIV-1 RNA 3.0, AMPLICOR HIV-1 MONITOR v1.5, and LCx® HIV RNA Quantitative assays Journal of Virological Methods ·Priscilla Swanson, Vera Holzmayer, Shihai Huang, Phillip Hay, Ade Adebiyi, Philip Rice, Klara Abravaya, M. Chubey, Sushil G. Devare, John Hackett	2006	46
10	Interleukin‐8 levels in seminal plasma in chronic prostatitis/chronic pelvic pain syndrome and nonspecific urethritis British Journal of Urology ·J. Van Beylen, Patricia Fletcher, Graz Luzzi, Robin J. Shattock, Phillip Hay	2006	57
11	Enfurvitide prevents vertical transmission of multidrug-resistant HIV-1 in pregnancy but does not cross the placenta AIDS ·陈浩伟 Hao-wei CHEN, Mark Pakianathan, Philip Rice, Stefano Bonora, Rana Chakraborty, Mike Sharland, Phillip Hay	2006	21
12	Prevalence of Mycoplasma genitalium in early pregnancy and relationship between its presence and pregnancy outcome BJOG An International Journal of Obstetrics & Gynaecology ·Pippa Oakeshott, Phillip Hay, D Taylor‐Robinson, Sima Hay, Birthe Dohn, Sally Kerry, Jørgen Skov Jensen	2004	58
13	Bacterial vaginosis and miscarriage Current Opinion in Infectious Diseases ·Phillip Hay	2004	44
14	Cervical Chlamydia trachomatis infection BMJ ·Pippa Oakeshott, Phillip Hay	2003	1
15	Recurrent bacterial vaginosis Current Infectious Disease Reports ·Phillip Hay	2000	49
16	Loss of CD4⁺T Cell Proliferative Ability but Not Loss of Human Immunodeficiency Virus Type 1 Specificity Equates with Progression to Disease The Journal of Infectious Diseases ·Jamie Wilson, Nesrina Imami, Amanda Watkins, M. N. Hafidzi, Phillip Hay, Brian Gazzard, Mike Westby, Frances Gotch	2000	109
17	Opportunistic screening for chlamydial infection at time of cervical smear testing in general practice: prevalence study BMJ ·Pippa Oakeshott, Sally Kerry, Sima Hay, Phillip Hay	1998	25
18	RECURRENT BACTERIAL VAGINOSIS Dermatologic Clinics ·Phillip Hay	1998	21
19	Therapy of bacterial vaginosis Journal of Antimicrobial Chemotherapy ·Phillip Hay	1998	24
20	Diagnosis of bacterial vaginosis in a gynaecology clinic BJOG An International Journal of Obstetrics & Gynaecology ·Phillip Hay, D Taylor‐Robinson, Ronnie Lamont	1992	60

About Phillip Hay

Phillip Hay is a scholar working on Microbiology, Virology, Epidemiology, Infectious Diseases and Rheumatology, having authored 116 papers that have together received 4.3k indexed citations. Recurring topics across this work include Reproductive tract infections research (77 papers), Urinary Tract Infections Management (37 papers), Syphilis Diagnosis and Treatment (23 papers), HIV/AIDS drug development and treatment (16 papers), Adolescent Sexual and Reproductive Health (16 papers), HIV Research and Treatment (16 papers), HIV/AIDS Research and Interventions (16 papers) and Cervical Cancer and HPV Research (14 papers). The work is most often cited by research in Microbiology (2.0k citations), Virology (472 citations), Epidemiology (1.6k citations), Infectious Diseases (805 citations) and Pharmacology (350 citations). Phillip Hay has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include D Taylor‐Robinson, Pippa Oakeshott, Austin Ugwumadu, Fiona Reid, Isaac Manyonda, Janez Tomažič, Sorin Rugină, Elizabeth J. Phillips, Sara Hughes and Arlene R. Hughes. Their work appears in journals such as Sexually Transmitted Infections, International Journal of STD & AIDS, BJOG An International Journal of Obstetrics & Gynaecology, Clinical Infectious Diseases and Current Opinion in Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact